|

StableEyes With Active Neurofeedback

RECRUITINGN/ASponsored by Johns Hopkins University
Actively Recruiting
PhaseN/A
SponsorJohns Hopkins University
Started2022-08-08
Est. completion2026-09-30
Eligibility
Age21 Years – 70 Years
Healthy vol.Accepted
Locations2 sites

Summary

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.

Eligibility

Age: 21 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Provision of signed and dated informed consent form
2. Stated willingness to comply with all study procedures and availability for the duration of the study
3. In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma
4. Willing to adhere to the SWAN and/or vestibular rehabilitation regimen

Exclusion Criteria:

1. Current use of anti-nausea medication
2. Presence of cervical spine pathology that limits head motion to \< 30 degrees in the horizontal or vertical plane (i.e. degenerative disc disease, rheumatoid arthritis)
3. Any orthopedic pathology that prevents walking or standing independently (i.e. recent surgery)
4. Legal blindness (20/200 or worse visual acuity)
5. Treatment using a motion sickness investigational drug or other motion sickness behavioral intervention within 30 days

Conditions5

CancerMotion SicknessSpace Motion SicknessVestibular DisorderVestibular Schwannoma

Locations2 sites

Maryland

1 site
Johns Hopkins University
Baltimore, Maryland, 21287
Michael C Schubert, PhD410-955-3403mschube1@jhmi.edu

Ohio

1 site
Naval Medical Research Unit
Dayton, Ohio, 45433

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.